J3415 HCPCS code: Injection, pyridoxine hcl, 100 mg
J3415 is the HCPCS Level II code for injection, pyridoxine hcl, 100 mg. In 2024 Medicare paid an average of $10.63 per service for J3415 across 105,351 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 6 per day on outpatient hospital claims. Medicare volume fell 68% from 2022 to 2024 (324,864 to 105,351 services). In 2024, about 278 clinicians billed Medicare for J3415 for 5,337 beneficiaries; Oklahoma, California, Virginia accounted for 65% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2004-01-01 |
| Last action effective | 2004-01-01 |
Who bills J3415 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 278 |
| Medicare beneficiaries | 5,337 |
| States with claims | 25 |
| Share of services in top 3 states (Oklahoma, California, Virginia) | 65% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J3415, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 324,864 | 8,549 | $8.58 | $6.78 |
| 2023 | 152,258 | 6,341 | $11.12 | $8.73 |
| 2024 | 105,351 | 5,337 | $13.53 | $10.63 |
States with the most J3415 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Oklahoma | 37,792 | $11.02 |
| California | 21,085 | $10.47 |
| Virginia | 9,703 | $10.60 |
| Florida | 7,167 | $8.27 |
| New York | 5,745 | $10.61 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 6 | Prescribing Information |
| practitioner claims | 6 | Prescribing Information |
What changed for J3415
- 2004-01-01: J3415 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J3415?
J3415 is the HCPCS Level II code for injection, pyridoxine hcl, 100 mg. Short descriptor: "Pyridoxine hcl 100 mg".
How much does Medicare pay for J3415?
In 2024, the average Medicare payment was $10.63 per service (average allowed $13.53).
Does Medicare cover J3415?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J3415 can be billed per day?
6 on outpatient hospital claims; 6 on practitioner claims (NCCI medically unlikely edits).
Related J34 codes
- J3400 — Injection, triflupromazine hcl, up to 20 mg
- J3401 — Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
- J3402 — Injection, remestemcel-l-rknd, per therapeutic dose
- J3403 — Revakinagene taroretcel-lwey, per implant
- J3404 — Injection, zopapogene imadenovec-drba suspension, per therapeutic dose
- J3405 — Injection, onasemnogene abeparvovec-brve, per treatment
- J3406 — Injection, omidubicel-onlv, per therapeutic dose
- J3410 — Injection, hydroxyzine hcl, up to 25 mg
- J3411 — Injection, thiamine hcl, 100 mg
- J3420 — Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
- J3424 — Injection, hydroxocobalamin, intravenous, 25 mg
- J3425 — Injection, hydroxocobalamin, intramuscular, 10 mcg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J3415
- Watch J3415 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J3415
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.